Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x100px

Product › Details

protein degradation technology

	Next higher product group	drug development technology

Record changed: 2023-07-10

Picture Berlin Partner Events RegMed Forum 2025 HealthCapital 650x200px

More documents for protein degradation technology

[1] Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin....
[2] C4 Therapeutics, Inc.. (3/4/24). "Press Release: C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins". Watertown, MA....
[3] Sibylla Biotech S.p.A.. (10/4/22). "Press Release: Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform". Verona....
[4] Proxygen GmbH. (6/2/22). "Press Release: Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders". Vienna....
[5] Monte Rosa Therapeutics, Inc.. (6/23/21). "Press Release: Monte Rosa Therapeutics Announces Pricing of Initial Public Offering". Boston, MA....
[6] Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam....
[7] Boehringer Ingelheim. (12/7/20). "Press Release: Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders – a Novel Approach to Fight Cancer". Ingelheim & Vienna....
[8] C4 Therapeutics, Inc.. (6/16/20). "Press Release: C4 Therapeutics Raises $170 Million Financing to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-concept and to Advance Proprietary Platform". Watertown, MA....
[9] Bayer AG. (10/1/19). "Press Release: Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio". Monheim, Boston, MA & New Haven, CT....
[10] Arvinas, Inc.. (6/4/19). "Press Release: Bayer and Arvinas to Collaborate on Human PROTAC Therapies and Launch a Separate Joint Venture to Develop Agricultural PROTAC Applications". New Haven, CT....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)